Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global zika virus therapeutics market stood at a value of around USD 19.69 billion in 2023. The industry is further projected to grow at a CAGR of 5.6% over the forecast period of 2024-2032 to attain USD 32.15 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global zika virus therapeutic market is being driven by the rising demand to prevent the virus from spreading, rapid technological advancements leading to the development of vaccines to fight it, along with the increased R&D in the field of zika virus RNA treatment.
Zika virus infection is triggered by an Aedes mosquito-borne virus that bites during the day. In general, the symptoms include fever, rash, conjunctivitis, muscle and joint pain, malaise, or headache.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the product type, the industry can be segmented into:
The EMR report further looks into the regional zika virus therapeutics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The global zika virus therapeutics market is being supported by the growing incidences of zika virus infection, which is gradually reaching epidemic proportions throughout the world. Zika virus infection have the ability to affect both adults and foetuses in the form of different clinical manifestations such as low-grade fever combined with arthralgia, conjunctivitis, pruritic maculopapular rashes, optic neuropathy, microcephalus, and congenital glaucoma. Especially in Latin America and the Caribbean, the number of instances of zika virus infection and related comorbidities is anticipated to increase considerably, leading to the growth of zika virus therapeutics market in the region and further aiding the global industry growth. The need to prevent and treat zika-related congenital disabilities and the development of the latest vaccines to prevent the further spread of the virus is aiding the growth of the industry globally. North America is anticipated to dominate the global zika virus therapeutics market over the forecast period. Within North America, the U.S. holds the most extensive industry-sponsored clinical trials.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global zika virus therapeutics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2023, the global zika virus therapeutics market attained a value of nearly USD 19.69 billion.
The market is projected to grow at a CAGR of 5.6% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 32.15 billion by 2032.
The major drivers of the market include growing incidences of zika virus infection and development of vaccines.
Increasing research and development (R&D) activities and technological advancements are the key trends propelling the growth of the market.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major products include acetaminophen and other NSAIDs.
The major players in the market are Aurobindo Pharma Ltd., Johnson & Johnson Services, Inc., Perrigo Co. Plc, Sun Pharmaceutical Industries Ltd., and Takeda Pharmaceutical Company Limited, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share